Cancer-related hair loss is primarily associated with cancer treatments.
Hair loss due to chemotherapy or radiation results from the cessation of growth in hairs that are in the anagen phase of the growth cycle.
In the case of chemotherapy, about 90% of the hair is affected.
In most cases, however, hair growth resumes afterward, as unlike cancer cells, normal cells recover.
In the case of radiation therapy, the loss is localized to the area of radiation.
The result is reversible for low-frequency radiation, although changes in hair quality may occur.
In some cases, however, hair growth may not resume.
While hair loss generally does not seem to be associated with an increased risk of cancer, men with androgenetic alopecia appear to have a 40% increased risk of developing prostate cancer. This is likely due to the association of the hormone DHT with both conditions.
However, the risk of developing non-aggressive prostate cancer does not seem to be increased in patients with androgenetic alopecia.